West Virginia University Cancer Institute's Clinical Research Unit (CRU) is dedicated to providing the services and expertise that investigators need to conduct clinical trials and expand the growing body of biomedical knowledge. We offer a wide range of administrative and budgetary services to both clinical investigators and private industry. Because West Virginia University is the state's primary research institution, the CRU physicians represent a comprehensive range of specializations. Our staff has a sterling reputation for excellent patient care as well as timely delivery of valid and reliable data. Unlike many other academic health centers, West Virginia University provides primary care services to a large, stable population of rural patients. WVU also provides secondary and tertiary care. Our patient population ensures a high degree of follow-up care and study completion that many other clinical trials facilities cannot offer. Clinical trials are conducted at the West Virginia University Cancer Institute and the Robert C. Byrd Health Sciences Center (HSC) at West Virginia University in Morgantown.
The WVU Cancer Institute is recruiting participants for an immunotherapy clinical trial for patients with metastatic melanoma or recurrent or metastatic head and neck squamous cell carcinoma.
Researchers at the West Virginia University Cancer Institute are evaluating a first-of-its-kind blood test for detecting colorectal cancer. Their findings may help propel the test toward inclusion in the U.S. Preventive Services Task Force’s recommendations for colorectal cancer screening.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few.